Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value

被引:25
|
作者
Fahim, Sarah Atef [1 ]
Abdullah, Mahmoud Salah [2 ]
Espinoza-Sanchez, Nancy A. [3 ]
Hassan, Hebatallah [4 ]
Ibrahim, Ayman M. [4 ]
Ahmed, Sarah Hamdy [2 ]
Shakir, George [2 ,5 ]
Badawy, Mohamed A. [6 ]
Zakhary, Nadia, I [7 ]
Greve, Burkhard [8 ]
El-Shinawi, Mohamed [9 ]
Gotte, Martin [3 ]
Ibrahim, Sherif Abdelaziz [4 ]
机构
[1] Cairo Univ, Fac Sci, Chem Dept, Biochem Program, Giza 12613, Egypt
[2] Cairo Univ, Fac Sci, Chem Dept, Biotechnol Biomol Chem Program, Giza 12613, Egypt
[3] Munster Univ Hosp, Dept Gynecol & Obstet, D-48149 Munster, Germany
[4] Cairo Univ, Fac Sci, Dept Zool, Giza 12613, Egypt
[5] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent, D-80539 Munich, Germany
[6] Cairo Univ, Fac Sci, Chem Dept, Giza 12613, Egypt
[7] Cairo Univ, Natl Canc Inst, Canc Biol Dept, Cairo 11796, Egypt
[8] Univ Hosp Munster, Dept Radiotherapy Radiooncol, D-48149 Munster, Germany
[9] Ain Shams Univ, Fac Med, Dept Gen Surg, Cairo 11566, Egypt
关键词
inflammatory breast cancer; microRNAs; miR-181b-5p; miR-200b-3p; miR-200c-3p; miR-203a-3p; miR-1-3p; ZEB2; hub genes; EPITHELIAL-MESENCHYMAL TRANSITION; THERAPEUTIC TARGETS; REPRESSORS ZEB1; CELL-MIGRATION; CANCER-CELLS; FAMILY; PROLIFERATION; SURVIVAL; MIR-1; METASTASIS;
D O I
10.3390/biom10071059
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inflammatory breast cancer (IBC) is a rare yet aggressive breast cancer variant, associated with a poor prognosis. The major challenge for IBC is misdiagnosis due to the lack of molecular biomarkers. We profiled dysregulated expression of microRNAs (miRNAs) in primary samples of IBC and non-IBC tumors using human breast cancer miRNA PCR array. We discovered that 28 miRNAs were dysregulated (10 were upregulated, while 18 were underexpressed) in IBC vs. non-IBC tumors. We identified 128 hub genes, which are putative targets of the differentially expressed miRNAs and modulate important cancer biological processes. Furthermore, our qPCR analysis independently verified a significantly upregulated expression of miR-181b-5p, whereas a significant downregulation of miR-200b-3p, miR-200c-3p, and miR-203a-3p was detected in IBC tumors. Receiver operating characteristic (ROC) curves implied that the four miRNAs individually had a diagnostic accuracy in discriminating patients with IBC from non-IBC and that miR-203a-3p had the highest diagnostic value with an AUC of 0.821. Interestingly, a combination of miR-181b-5p, miR-200b-3p, and miR-200c-3p robustly improved the diagnostic accuracy, with an area under the curve (AUC) of 0.897. Intriguingly, qPCR revealed that the expression of zinc finger E box-binding homeobox 2 (ZEB2) mRNA, the putative target of miR-200b-3p, miR-200c-3p, and miR-203a-3p, was upregulated in IBC tumors. Overall, this study identified a set of miRNAs serving as potential biomarkers with diagnostic relevance for IBC.
引用
收藏
页码:1 / 30
页数:30
相关论文
共 50 条
  • [31] miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK
    Wang, Xiaoxi
    Jia, Yanfei
    Li, Qiang
    Yang, Yiang
    Liu, Yingfeng
    Wei, Beifeng
    Niu, Xiang
    Zhang, Yinjie
    Luo, Xiaodong
    Zhao, Ziyu
    Wang, Peng
    ONCOLOGY RESEARCH, 2024, 32 (05) : 933 - 941
  • [32] Predicting the possible effect of miR-203a-3p and miR-29a-3p on DNMT3B and GAS7 genes expression
    Ali, Afgar
    Mahla, Sattarzadeh Bardsiri
    Reza, Vahidi
    Alireza, Farsinejad
    JOURNAL OF INTEGRATIVE BIOINFORMATICS, 2022, 19 (01)
  • [33] TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells
    Janiak, Marek
    Paskal, Wiktor
    Rak, Beata
    Garbicz, Filip
    Jarema, Robert
    Sikora, Krzysztof
    Wlodarski, Pawel
    APMIS, 2017, 125 (02) : 101 - 105
  • [34] MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer
    Carvalho, Tamyres Mingorance
    Brasil, Guillermo Ortiz
    Jucoski, Tayana Schultz
    Adamoski, Douglas
    de Lima, Rubens Silveira
    Spautz, Cleverton C.
    Anselmi, Karina Furlan
    Ozawa, Patricia Midori Murobushi
    Cavalli, Iglenir Joao
    de Oliveira, Jaqueline Carvalho
    Gradia, Daniela Fiori
    Ribeiro, Enilze Maria de Souza Fonseca
    FRONTIERS IN GENETICS, 2022, 13
  • [35] The expression of miR-181a-5p and miR-371b-5p in chondrosarcoma
    Mutlu, S.
    Mutlu, H.
    Kirkbes, S.
    Eroglu, S.
    Kabukcuoglu, Y. S.
    Kabukcuoglu, F.
    Duymus, T. M.
    Isik, M.
    Ulasli, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (13) : 2384 - 2388
  • [36] 外周血miR-200c-3p、miR-99b-5p和miR-150-5p作为缺血性脑卒中生物标记物的研究
    易朝晖
    黄素丽
    张艳炜
    周世权
    吕子全
    李山山
    谢昌辉
    程锦泉
    中华神经医学杂志, 2015, 14 (06) : 597 - 603
  • [37] Circulating miR-3613-5p but not miR-125b-5p, miR-199a-3p, and miR-451a are biomarkers of endometriosis
    Walasik, Izabela
    Klicka, Klaudia
    Grzywa, Tomasz M.
    Szymusik, Iwona
    Wielgos, Miroslaw
    Pietrzak, Bronislawa
    Ludwin, Artur
    Wlodarski, Pawel
    REPRODUCTIVE BIOLOGY, 2023, 23 (04)
  • [38] Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer
    Xia, Lei
    Han, Qing
    Chi, Chenfei
    Zhu, Yinjie
    Pan, Jiahua
    Dong, Baijun
    Huang, Yiran
    Xia, Weiliang
    Xue, Wei
    Sha, Jianjun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 124
  • [39] Differential Expression of MiR-106b-5p and MiR-200c-3p in Newly Diagnosed Versus Chronic Primary Immune Thrombocytopenia Patients Based on Systematic Analysis
    Qian, Cheng
    Yan, Wenying
    Li, Tengda
    Cui, Qingya
    Liu, Peng
    Gu, Mingli
    Guo, Jie
    Zhang, Weiwei
    Ren, Chuanlu
    Wu, Tianqin
    Deng, Anmei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 45 (01) : 301 - 318
  • [40] Integrated MicroRNA Expression Profile Reveals Dysregulated miR-20a-5p and miR-200a-3p in Liver Fibrosis
    Ye, Mu
    Wang, Sheng
    Sun, Peilong
    Qie, Jingbo
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021